US FDA declines to approve Regenxbio's rare disease drug

Core Viewpoint - Regenxbio announced that the U.S. Food and Drug Administration has declined to approve its drug for a rare disease [1] Company Summary - Regenxbio's drug was intended for a rare disease but has not received FDA approval [1]